Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Advocacy Groups Say POM Claims Prey On Consumer Desperation

This article was originally published in The Tan Sheet

Executive Summary

“Consumers may be desperate to find a cure or treatment for their disease when conventional treatment has not worked … and turn to food products or dietary supplements,” CSPI and Public Citizen attorneys say in an amicus brief supporting FTC’s enforcement against POM.

Advertisement

Related Content

Supplement Industry Critics On Agenda For FDA's Ingredient List Meeting
POM Wonderful Asks Court To Vacate “Draconian” FTC Order

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS107401

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel